Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

LFSC vs FBDIX overlap: 18% of top holdings shared

Bottom line

How much do LFSC and FBDIX overlap?

18% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 24.3% of LFSC's assets and 11.8% of FBDIX's. They are substantially different portfolios, so owning both adds real diversification.

FBDIX holds far more positions (126 vs 40), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

LFSCFBDIX
Weight overlap (top 25)18%
Shared holdings6
Weight in shared holdings24.3%11.8%
Total positions40126
Expense ratio0.54%1.01%
Holdings as ofMay 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Holdings LFSC and FBDIX have in common

Holding% of LFSC% of FBDIXOverlap
Spyre Therapeutics Inc SYRE6.41%1.87%1.87%
Guardant Health Inc GH5.52%2.76%2.76%
Mirum Pharmaceuticals Inc MIRM4.92%1.98%1.98%
Cytokinetics Inc CYTK3.16%1.24%1.24%
Dianthus Therapeutics Inc DNTH3.09%2.32%2.32%
Bridgebio Pharma Inc BBIO1.17%1.67%1.17%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in LFSC

  1. Travere Therapeutics Inc — 7.67%
  2. Cogent Biosciences Inc — 7.53%
  3. LivaNova PLC — 7.11%
  4. Corcept Therapeutics Inc — 4.79%
  5. United Therapeutics Corp — 4.16%
  6. VeraDermics Inc — 3.42%
  7. Savara Inc — 3.22%
  8. Nektar Therapeutics — 3.14%
  9. Trevi Therapeutics Inc — 3.12%
  10. Axsome Therapeutics Inc — 2.84%
  11. Billiontoone Inc — 2.73%
  12. TransMedics Group Inc — 2.68%
  13. Viridian Therapeutics Inc — 2.24%
  14. ICU Medical Inc — 2.09%
  15. Corvus Pharmaceuticals Inc — 1.95%

Only in FBDIX

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Amgen, Inc. — 4.39%
  3. Gilead Sciences, Inc. — 3.86%
  4. Regeneron Pharmaceuticals, Inc. — 3.77%
  5. Argenx SE — 3.62%
  6. Vertex Pharmaceuticals, Inc. — 3.54%
  7. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  8. Revolution Medicines, Inc. — 3.01%
  9. Ascendis Pharma A/S — 2.56%
  10. Insmed, Inc. — 1.99%
  11. Praxis Precision Medicines, Inc. — 1.91%
  12. Oruka Therapeutics, Inc. — 1.86%
  13. Neurocrine Biosciences, Inc. — 1.82%
  14. PTC Therapeutics, Inc. — 1.65%
  15. AstraZeneca plc — 1.51%

Asset mix

Asset typeLFSCFBDIX
Stocks100.0%97.0%
Cash & short-term funds—4.6%
Preferred stock—1.0%
Other—0.6%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Country mix

CountryLFSCFBDIX
US92.0%82.0%
GB7.1%1.5%
IE—6.7%
NL—4.5%
DK—2.6%
FR—1.7%
CA—1.3%
CH—1.2%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do LFSC and FBDIX overlap?
About 18% by weight. 6 securities appear in both funds' top 25 holdings; they make up 24.3% of LFSC's assets and 11.8% of FBDIX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do LFSC and FBDIX have in common?
The largest shared holdings are Guardant Health Inc, Dianthus Therapeutics Inc, Mirum Pharmaceuticals Inc, Spyre Therapeutics Inc, Cytokinetics Inc.
Should I own both LFSC and FBDIX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, LFSC or FBDIX?
FBDIX is broader, with 126 positions versus 40 for LFSC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.